Genmab — Maj 2025

[Solsen]

RinaS seems to have the power to wipeout Alahere. My guess is +$3bn in peaksale. That could close half the gap from dara.

[E_L]

you could be right, they are also actively enrolling lung cancer patients "And, there will be more activity on this. I promise you very soon, that we can also share, in the public domain." said Tahi

[E_L]

$3bn in peaksale would close the gap from dara -in revenue, wouldn't it, before development and sales cost

[Sukkeralf]

But a very big issue is still that Genmab is not even close to do global sales - and this will not happen before Darzalex royalty expire

[Sukkeralf]

And peaksales for RinaS will take many years to build up

[E_L]

sure. but if you don't have the aspirations you'll never get there. It also works the other way around right -if you have a drug that gives you the confidence it will be a big seller, it will also give you the confidence to ramp up the sales organisation.

[E_L]

They'll have to start with Tivdak in europe this year, still a smaller drug, but similar patient group, so it is the same trajectory they will need to follow for Rina-S

[w]

@17.43. If that was not the case. PE would have been far above 10

[Helge_LarsenPI-redaktør]

Godmorgen

[ProinvestorNEWS]

Trump vil presse medicinpriserne markant ned i USA https://www.dr.dk/nyheder/udland/trump-vil-saenke-priserne-paa-medicin-i-usa-markant

[ProinvestorNEWS]

"Nyhedsbureauet AP skriver, at Trumps forslag sandsynligvis kun vil sænke priserne på de lægemidler, der er dækket af den offentlige sundhedsforsikring Medicare.

Medicare udgør en hjørnesten i det amerikanske sundhedssystem og sikrer sundhedsdækning for omkring 70 millioner ældre borgere".

[ProinvestorNEWS]

Er Donald Trump medicinmanden med de lavere priser? https://proinvestor.com/boards/126321

[LP90]

Godmorgen

[Solsen]

Puha det kan blive volatilt med de udmeldinger. Trump mener, at priserne på medicin skal ned med 30-80% i USA.

[E_L]

this was why we went down on Thursday already , didn't we...

[E_L]

Dose Selection for DuoBody-CD40x4-1BB (GEN1042/BNT312) Using a mPBPK/RO Model Leveraging Preclinical and Clinical Data https://ascpt.onlinelibrary.wiley.com/doi/full/10.1002/cpt.3677

[Plimsoller]

Vi får en ordentlig en på hatten lige nu. Lad os se hvad der sker i løbet af dagen. Sidste gang han forsøgte noget lignende blev han jo stoppet af domstolene.

[LP90]

den her case har udviklet sig til et mareridt for rigtig mange incl. mig selv øv øv øv

[Raun]

Her er jeg total i chok!..... Jeg fatter ikke en skid af det der foregår..... Hvorfor er Genmab den aktie der konstant skal rammes hårdest, når idioten DT åbner sin mund?..... Genmab hører vel til den gruppe der bliver mindst ramt af DT tankespind...

[Raun]

??.... På bare en uge har Genmab aktien smidt over 15%... Og det ovenikøbet med et godt regnskab inkluderet?